Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 22630149)

Published in Nanomedicine (Lond) on May 01, 2012

Authors

Dodi Safari1, Marco Marradi, Fabrizio Chiodo, Huberta A Th Dekker, Yulong Shan, Roberto Adamo, Stefan Oscarson, Ger T Rijkers, Martina Lahmann, Johannis P Kamerling, Soledad Penadés, Harm Snippe

Author Affiliations

1: Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Articles citing this

Multivalent glycoconjugates as anti-pathogenic agents. Chem Soc Rev (2012) 1.41

Synthetically defined glycoprotein vaccines: current status and future directions. Chem Sci (2013) 0.97

Gold nanoparticle mediated cancer immunotherapy. Nanomedicine (2013) 0.93

Clustered carbohydrates in synthetic vaccines. Chem Soc Rev (2012) 0.91

Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs. Beilstein J Org Chem (2014) 0.81

Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles. Acta Biomater (2013) 0.81

Novel nanoparticle vaccines for Listeriosis. Hum Vaccin Immunother (2015) 0.79

High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles. PLoS One (2013) 0.78

From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology. Vaccines (Basel) (2015) 0.77

Immunological properties of gold nanoparticles. Chem Sci (2016) 0.75

Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems. Vaccines (Basel) (2016) 0.75

Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities. Nanomaterials (Basel) (2016) 0.75

Structural Characterization of Bio-Functionalized Gold Nanoparticles by Ultrahigh Resolution Mass Spectrometry. ACS Nano (2017) 0.75

Articles by these authors

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet (2011) 7.15

Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol (2003) 3.70

Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol (2009) 2.27

Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods (2005) 2.09

Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet (2005) 1.93

Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol (2005) 1.90

Solid-phase and bead-based cytokine immunoassay: a comparison. Methods (2006) 1.87

Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol (2012) 1.66

Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis. Eur Respir J (2013) 1.56

Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One (2008) 1.54

Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia. J Infect (2012) 1.50

Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol (2012) 1.47

Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. Biochim Biophys Acta (2005) 1.42

Multivalent glycoconjugates as anti-pathogenic agents. Chem Soc Rev (2012) 1.41

Characterization of Romboutsia ilealis gen. nov., sp. nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intestinibacter gen. nov., Terrisporobacter gen. nov. and Asaccharospora gen. nov. Int J Syst Evol Microbiol (2014) 1.34

Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum (2002) 1.30

Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect (2003) 1.30

A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet (2011) 1.28

The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Mol Microbiol (2006) 1.28

Gold glyconanoparticles as new tools in antiadhesive therapy. Chembiochem (2004) 1.25

A lectin array-based methodology for the analysis of protein glycosylation. J Biochem Biophys Methods (2006) 1.24

Return of Haemophilus influenzae type b infections. Lancet (2003) 1.24

Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol (2008) 1.22

Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions This work was supported by the DGICYT (PB96-0820), J.M.F. thanks the MEC for a predoctoral fellowship. A.G.B. thanks CSIC for financial support. We thank Prof. Martín-Lomas for his scientific and financial support. Angew Chem Int Ed Engl (2001) 1.21

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr (2010) 1.18

Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery (2007) 1.16

Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis (2014) 1.15

Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr (2007) 1.15

Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. Chemistry (2003) 1.14

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr (2010) 1.13

Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev (2013) 1.13

EUROCarbDB: An open-access platform for glycoinformatics. Glycobiology (2010) 1.13

Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3. Glycobiology (2004) 1.12

The Giardia intestinalis filamentous cyst wall contains a novel beta(1-3)-N-acetyl-D-galactosamine polymer: a structural and conformational study. Glycobiology (2002) 1.11

Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides. Clin Vaccine Immunol (2008) 1.11

Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol (2006) 1.11

Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J Immunol (2003) 1.10

Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet (2002) 1.09

Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax (2007) 1.08

Ethyl 2-acetamido-4,6-di-O-benzyl-2,3-N,O-carbonyl-2-deoxy-1-thio-beta-D-glycopyranoside as a versatile GlcNAc donor. Chem Commun (Camb) (2005) 1.07

Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197. Infect Immun (2002) 1.07

Interactions of substrate with calreticulin, an endoplasmic reticulum chaperone. J Biol Chem (2002) 1.06

Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydr Res (2006) 1.06

Nidovirus sialate-O-acetylesterases: evolution and substrate specificity of coronaviral and toroviral receptor-destroying enzymes. J Biol Chem (2004) 1.04

The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH. Biochemistry (2012) 1.04

Photogenerated glycan arrays identify immunogenic sugar moieties of Bacillus anthracis exosporium. Proteomics (2007) 1.03

Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr (2010) 1.03

Thermodynamic, kinetic, and electron microscopy studies of concanavalin A and Dioclea grandiflora lectin cross-linked with synthetic divalent carbohydrates. J Biol Chem (2005) 1.03

Mutational analysis provides molecular insight into the carbohydrate-binding region of calreticulin: pivotal roles of tyrosine-109 and aspartate-135 in carbohydrate recognition. Biochemistry (2004) 1.03

Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. Clin Infect Dis (2001) 1.02

Critical elements of oligosaccharide acceptor substrates for the Pasteurella multocida hyaluronan synthase. J Biol Chem (2005) 1.02

Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14. Infect Immun (2008) 1.02

The fucose-binding lectin from Ralstonia solanacearum. A new type of beta-propeller architecture formed by oligomerization and interacting with fucoside, fucosyllactose, and plant xyloglucan. J Biol Chem (2005) 1.01

Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3. Infect Immun (2003) 1.01

Nanostructured disposable impedimetric sensors as tools for specific biomolecular interactions: sensitive recognition of concanavalin A. Anal Chem (2011) 1.01

The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies. Vaccine (2009) 1.00

Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv (2007) 1.00

The structure of cell wall alpha-glucan from fission yeast. Glycobiology (2004) 1.00

A TNF-like trimeric lectin domain from Burkholderia cenocepacia with specificity for fucosylated human histo-blood group antigens. Structure (2010) 1.00

Immunogens related to the synthetic tetrasaccharide side chain of the Bacillus anthracis exosporium. Bioorg Med Chem (2007) 0.99

Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res (2007) 0.99

26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition. Nutrition (2011) 0.99

Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration (2008) 0.99

Beta-propeller crystal structure of Psathyrella velutina lectin: an integrin-like fungal protein interacting with monosaccharides and calcium. J Mol Biol (2006) 0.98

4,6-α-glucanotransferase, a novel enzyme that structurally and functionally provides an evolutionary link between glycoside hydrolase enzyme families 13 and 70. Appl Environ Microbiol (2011) 0.98

Structural basis for ligand and substrate recognition by torovirus hemagglutinin esterases. Proc Natl Acad Sci U S A (2009) 0.98

Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. Chemistry (2009) 0.98

The fimbrial adhesin F17-G of enterotoxigenic Escherichia coli has an immunoglobulin-like lectin domain that binds N-acetylglucosamine. Mol Microbiol (2003) 0.98

Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin Infect Dis (2012) 0.97

Thermodynamic evidence for Ca2+-mediated self-aggregation of Lewis X gold glyconanoparticles. A model for cell adhesion via carbohydrate-carbohydrate interaction. J Am Chem Soc (2005) 0.97

Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults. Vaccine (2009) 0.96

Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection. Clin Diagn Lab Immunol (2005) 0.96

Studies toward a conjugate vaccine for anthrax. Synthesis and characterization of anthrose [4,6-dideoxy-4-(3-hydroxy-3-methylbutanamido)-2-O-methyl-D-glucopyranose] and its methyl glycosides. Carbohydr Res (2005) 0.95

N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. Glycobiology (2003) 0.95

Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media. Clin Infect Dis (2004) 0.95

Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. Bioconjug Chem (2012) 0.95

An in vitro bioassay to determine individual sensitivity to glucocorticoids: induction of FKBP51 mRNA in peripheral blood mononuclear cells. Mol Cell Endocrinol (2004) 0.95

Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes. J Inflamm (Lond) (2012) 0.95

Isothermal titration calorimetric study defines the substrate binding residues of calreticulin. Biochem Biophys Res Commun (2006) 0.95

Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies. J Nutr (2009) 0.95

Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res (2006) 0.94